Clinical Trials Directory

Trials / Sponsors / Yungjin Pharm. Co., Ltd.

Yungjin Pharm. Co., Ltd.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adul
Gastroesophageal Reflux Disease
Phase 12021-01-13
CompletedEvaluate the Pharmacokinetic Characteristics and Safety/Tolerability of YNP-1807 Compared to Lyrica® After Ora
Healthy
Phase 12017-09-14
CompletedSafety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers
MELAS Syndrome, Mitochondrial Respiratory Chain Deficiencies
Phase 12017-06-26
CompletedA Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 22017-04-01
CompletedA Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients
Chronic Obstructive Pulmonary Disease
Phase 22015-06-04
CompletedSafety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers
Metabolic Syndrome
Phase 12015-01-01
CompletedA Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Steno
Neurologic Claudication in Patients With Lumbar Spinal Stenosis
Phase 42013-02-01
TerminatedTherapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoh
Nonalcoholic Fatty Liver Disease
Phase 22013-01-01
CompletedPhase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syn
Dry Eye Syndrome
Phase 22012-10-01
CompletedAssessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination
Pain
Phase 12012-01-01
CompletedSafety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers
Metabolic Syndrome, Obesity
Phase 12011-04-01
CompletedSafety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers
Metabolic Syndrome, Obesity
Phase 12010-07-01